206 related articles for article (PubMed ID: 2061449)
21. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.
Katz R; Fischmann AB; Galotto J; Guccio JG; Higgins GA; Ortega LG; West WH; Recant L
Cancer; 1979 Aug; 44(2):558-63. PubMed ID: 476569
[TBL] [Abstract][Full Text] [Related]
22. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
Chang CH; Sheu HM; Cheng GS; Yu HS
J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
[TBL] [Abstract][Full Text] [Related]
23. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
[TBL] [Abstract][Full Text] [Related]
24. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
Saavedra C; Lamarca A; Hubner RA
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
[TBL] [Abstract][Full Text] [Related]
25. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
Wu SL; Bai JG; Xu J; Ma QY; Wu Z
World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
[TBL] [Abstract][Full Text] [Related]
26. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
27. [Facial erythema and pancreatic glucagonoma].
Erce C; Morales DJ; Diego L; Mazorra F; García de Polavieja M
Rev Esp Enferm Dig; 1997 Feb; 89(2):137-8. PubMed ID: 9115822
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
Boujan N; Géraud C
Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
[No Abstract] [Full Text] [Related]
29. Apoptosis with positive direct immunofluorescence findings in a patient with necrolytic migratory erythema.
Perniciaro C; Rappaport KD; White JW
Cutis; 1998 Sep; 62(3):129-32. PubMed ID: 9770127
[TBL] [Abstract][Full Text] [Related]
30. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
Toberer F; Hartschuh W; Wiedemeyer K
Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
[TBL] [Abstract][Full Text] [Related]
31. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
32. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
[TBL] [Abstract][Full Text] [Related]
33. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
34. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
[TBL] [Abstract][Full Text] [Related]
35. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
36. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
Skouge JW; Farmer ER
Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
[No Abstract] [Full Text] [Related]
37. [Necrolytic migratory erythema associated with glucagonoma].
Mendoza-Guil F; Hernández-Jurado I; Burkhardt P; Linares J; Naranjo R
Actas Dermosifiliogr; 2005 Apr; 96(3):175-8. PubMed ID: 16476361
[TBL] [Abstract][Full Text] [Related]
38. [Necrolytic migratory erythema in a patient with a glucagonoma].
Demirbas M; Prens B
Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
[TBL] [Abstract][Full Text] [Related]
39. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
Zhu WF; Zheng SS
Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
[No Abstract] [Full Text] [Related]
40. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
Gantcheva ML; Broshtilova VK; Lalova AI
Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
